A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

NCT01730027 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ADC3680
DRUG: Placebo
DRUG: montelukast

Sponsor

Pulmagen Therapeutics